You're reading the free version. Trader adds the live tape and alerts.
Start tracking
INBX Buy Disclosure
Lappe Mark · SEC Form 4 · Filed Sep 28, 2026
Buy
Calculated transaction value
$328.63K
Lappe Mark Chief Executive Officer
INBX
Inhibrx Biosciences
INBX
Transaction date
Sep 25, 2026
Public filing date
Sep 28, 2026
Filing lag
Filed 3 days later
INBX daily price context
Close on/before transaction
$99.61
Sep 25, 2026
First close after public filing
$104.83
Sep 29, 2026
30-day return after filing
-30.09%
Through Oct 28, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,324 shares @ $98.87
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001366074-26-000004
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$998.78K
Buys / sales
4 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Inhibrx Biosciences, Inc. INBX | Buy | Sep 28, 2026 | $148.32K |
| Inhibrx Biosciences, Inc. INBX | Buy | Sep 28, 2026 | $305.11K |
| Inhibrx Biosciences, Inc. INBX Current | Buy | Sep 25, 2026 | $328.63K |
| Inhibrx Biosciences, Inc. INBX | Buy | Sep 25, 2026 | $216.73K |